Martin Pecherstorfer

Karl Landsteiner University of Health Sciences — Austria

Medicine · Health Sciences

34h-index4.0kcitations182works2.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bone health and treatments(52), Multiple Myeloma Research and Treatments(19), Radiopharmaceutical Chemistry and Applications(17), Bone and Joint Diseases(17), Cancer Diagnosis and Treatment(14)

Publications182 total

Real‑world evidence of imatinib treatment in younger and older patients with chronic myeloid leukaemia: A retrospective single centre analysis
Oncology Letters·2025Open Access
Palliative Radiotherapy Near the End of Life: An Analysis of Factors Influencing the Administration of Radiotherapy in Advanced Tumor Disease
JCO Global Oncology·2025Open Access
Treatment of stage IV colorectal cancer: A retrospective cohort study assessing whether failure of first‑line treatment indicates failure of second‑line treatment
Molecular and Clinical Oncology·2024Open Access
Favorable impact of PD1/PD-L1 antagonists on bone remodeling: an exploratory prospective clinical study and ex vivo validation
Journal for ImmunoTherapy of Cancer·2024· 11 citedOpen Access
Evaluation of 3GPP Release 16 Indoor Positioning in Private Standalone 5G Networks
2023· 6 cited
Evaluation of Antibody Responses in Patients with B-Cell Malignancies after Two and Three Doses of Anti-SARS-CoV-2 S Vaccination—A Retrospective Cohort Study
Cancers·2023· 3 citedOpen Access
Delineating CDK9- Regulated Molecular Events for the Development of Rationally Derived Multiple Myeloma Treatment Strategies
Blood·2022
1255 Impact of immune checkpoint inhibitors on bone turnover in cancer patients: prospective clinical study and preclinical correlates
Regular and Young Investigator Award Abstracts·2022· 1 citedOpen Access
On the continuous (R)evolution of antibody-based and CAR T cell therapies in multiple myeloma: an early 2022 glance into the future
Expert Opinion on Pharmacotherapy·2022· 3 cited
Evaluation of diagnostic and treatment approaches to acute dyspnea in a palliative care setting among medical doctors with different educational levels
Supportive Care in Cancer·2022· 2 citedOpen Access
Evaluation of Diagnostic and Treatment Approaches to Acute Dyspnea in a Palliative Care Setting Among Medical Doctors with Different Educational Levels
2021· 1 citedOpen Access
Evaluation of Ki-67 as a Prognostic Marker in Diffuse Large B-Cell Lymphoma—A Single-Center Retrospective Cohort Study
Current Oncology·2021· 20 citedOpen Access
Management of Adverse Events and Supportive Therapy in Relapsed/Refractory Multiple Myeloma
Cancers·2021· 18 citedOpen Access
OAB-030: Combined targeting of distinct c-Myc and JunB transcriptional programs induces synergistic anti-myeloma activity
Clinical Lymphoma Myeloma & Leukemia·2021
P-082: Delineating CDK9- regulated molecular events for the development of rationally derived multiple myeloma treatment strategies
Clinical Lymphoma Myeloma & Leukemia·2021· 1 cited
Publisher Correction: JunB is a key regulator of multiple myeloma bone marrow angiogenesis
Leukemia·2021· 2 citedOpen Access
Evaluation of Antibody Responses to COVID-19 Vaccines among Solid Tumor and Hematologic Patients
Cancers·2021· 16 citedOpen Access
Effect of cachexia on bone turnover in cancer patients: a case-control study
BMC Cancer·2021· 13 citedOpen Access
Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial
European Journal of Cancer·2021· 20 cited
JunB is a key regulator of multiple myeloma bone marrow angiogenesis
Leukemia·2021· 41 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Heinz Ludwig(12), Markus J. Seibel(7), Ingo Diel(6), Henning W. Woitge(6), Andrea Keck(6), D. Thiébaud(6), Sonia Vallet(6), E. Fritz(5), Clemens Leitgeb(5), Klaus Podar(5), Jean‐Jacques Body(4), J. C. Schuster(4), Eva Horn(4), Ilse Zimmer-Roth(4), Richard Greil(4), Johannes Andel(4), Tobias Schilling(4), H. Samonigg(3), Z. Herrmann(3), E.U. Steinhauer(3)